Bupropion hydrobromide and therapeutic applications

Details for Australian Patent Application No. 2008285660 (hide)

Owner Biovail Laboratories International SRL

Inventors Williams, Robert Parry; Silverstone, Peter Harris

Agent Davies Collison Cave

Pub. Number AU-A-2008285660

PCT Pub. Number WO2009/019294

Priority 11/834,848 07.08.07 US

Filing date 6 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 33/00 (2006.01) Medicinal preparations containing inorganic active ingredients

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019294 Priority application(s): WO2009/019294

16 February 2012 Alteration of Name

  The name of the applicant has been altered to Valeant International (Barbados) SRL

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285663-N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases

2008285659-Modified bacteriophage including an alpha/beta small acid-soluble spore protein (SASP) gene